BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31351495)

  • 21. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
    Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
    Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
    Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
    Saade RE; Bell D; Garcia J; Roberts D; Weber R
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature.
    De la Sancha C; Kuhar M; Kraft A; Alomari AK
    J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
    O'Neill ID
    Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.
    Jee KJ; Persson M; Heikinheimo K; Passador-Santos F; Aro K; Knuutila S; Odell EW; Mäkitie A; Sundelin K; Stenman G; Leivo I
    Mod Pathol; 2013 Feb; 26(2):213-22. PubMed ID: 23018873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new type of MAML2 fusion in mucoepidermoid carcinoma.
    Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells.
    Wu Y; He Z; Li S; Tang H; Wang L; Yang S; Dong B; Qin J; Sun Y; Yu H; Zhang Y; Zhang Y; Guo Y; Wang Q
    Curr Cancer Drug Targets; 2019; 19(10):796-806. PubMed ID: 30605061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.
    Bean GR; Krings G; Otis CN; Solomon DA; García JJ; van Zante A; Camelo-Piragua S; van Ziffle J; Chen YY
    Histopathology; 2019 Feb; 74(3):463-473. PubMed ID: 30380176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.
    O'Neill ID
    Lung Cancer; 2009 Apr; 64(1):129-30. PubMed ID: 19185385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spindle Cell Mucoepidermoid Carcinoma of the Palatine Tonsil With CRTC1-MAML2 Fusion Transcript: Report of a Rare Case in a 17-Year-Old Boy and a Review of the Literature.
    Goh GH; Lim CM; Vanacek T; Michal M; Petersson F
    Int J Surg Pathol; 2017 Dec; 25(8):705-710. PubMed ID: 28637362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
    Prieto-Granada CN; Inagaki H; Mueller J
    Int J Surg Pathol; 2015 Jun; 23(4):277-83. PubMed ID: 25782731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.
    Ishibashi K; Ito Y; Masaki A; Fujii K; Beppu S; Sakakibara T; Takino H; Takase H; Ijichi K; Shimozato K; Inagaki H
    Am J Surg Pathol; 2015 Nov; 39(11):1479-87. PubMed ID: 26457352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Reliability of CRTC1/3::MAML2 Gene Fusion Transcripts in Discriminating Histologically Similar Intraosseous Mucoepidermoid Carcinoma from Glandular Odontogenic Cyst: A Systematic Review and Meta-analysis.
    Keerthika R; Devi A; Kamboj M; Sivakumar N; Vijayakumar G; Narwal A; Girdhar A
    Head Neck Pathol; 2023 Mar; 17(1):233-245. PubMed ID: 36357765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.
    Roden AC; Erickson-Johnson MR; Yi ES; García JJ
    Hum Pathol; 2013 Dec; 44(12):2799-805. PubMed ID: 24134933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.
    Fujimaki M; Fukumura Y; Saito T; Mitani K; Uchida S; Yokoyama J; Yao T; Ikeda K
    Hum Pathol; 2011 Dec; 42(12):2052-5. PubMed ID: 21676434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjunctival Adenosquamous Carcinoma Lacks
    Lee A; Yuen HKL; Tham CCY; Cheuk W
    Int J Surg Pathol; 2020 Dec; 28(8):893-898. PubMed ID: 32476556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: Systematic review and meta-analysis.
    Pérez-de-Oliveira ME; Wagner VP; Araújo ALD; Martins MD; Santos-Silva AR; Bingle L; Vargas PA
    J Oral Pathol Med; 2020 May; 49(5):386-394. PubMed ID: 31661572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.
    Ge Y; Lin X; He J; Chen W; Lin D; Zheng Y; Yang L; Xu F; Li Z
    Diagn Pathol; 2024 Jan; 19(1):15. PubMed ID: 38243319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.